Coronary Angioplasty with Sirolimus Eluting Stents

At present, most percutaneous coronary intervention procedures (PCI) are done with drug eluting stents (DES). However, drug coated balloons (DCB) have shown benefits in restenosis and small vessel de novo lesions. 

Intravascular ultrasound (IVUS) has been shown effective in left main PCI and complex procedures, even though there is little infomration on its use for PCIs with DCB. 

The ULTIMATE III is a clinical randomized controlled open study comparing IVUS guided against angiography guided PCI in patients at high risk of bleeding.

The study included 260 patients with ≤15 mm, 2 to 4 mm in diameter lesions.

Primary end point was late lumen loss (LLL) at 7 months. Patient groups were similar as to demographic and clinical characteristics: mean age 67, 80% were men, 72% were hypertensive, 30% diabetic, 9% had a history of MI, 17% prior PCI, 9% ictus, 5% peptic ulcer, 12% atrial fibrillation, 45% anemia, 10% <100,000 platelet count and 14% kidney function deterioration. 

Read also: Patients with CABG History and new N-ST ACS: Routine Invasive Strategy?

The most frequent clinical presentation was unstable angina (73%), followed by stable chronic angina (14%), and less frequently ST elevation acute myocardial infarction (STEMI), non-ST elevation acute MI (NSTEMI), and silent ischemia. 

There were no differences in lesion localization, the anterior descending being the most affected, followed by the circumflex. Neither were there significant differences in procedure. 

Primary end point resulted favorable for patients receiving IVUS guided PCI (0.03±0.52 mm for ANGIO PCI vs. 0.10±0.34 mm for IVUS PCI; mean difference 0.14 mm; CI 95%: 0.02-0.26; P = 0.025). Also, IVUS PCI was associated with less stenosis (28.15%±13.88% vs. 35.83%±17.69%; P = 0.001) and larger intraluminal diameter (2.06±0.62 mm vs. 1.75±0.63 mm; P < 0.001).

Conclusion

This study has shown IVUS guided PCI is associated with less late lumen loss in patients with de novo coronary lesions vs. angiography guided PCI.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Intravascular Ultrasound vs Angiography- Guided Drug-Coated Balloon Angioplasty. 

Reference: The ULTIMATE III Trial. Xiao-Fei Gao, et al. J Am Coll Cardiol Intv 2024. Article in Press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....